Search
01/03/2025
Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort
Uleri, A, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, An-Nader, M, Dariane, C, Baud, H, Olivier, J, Sanguedolce, F, Rios, AR, Bernard,, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G, Baboudjian, M. Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy
Pecoraro, A, Catucci, CL, Territo, A, Gallioli, A, Etcheverry, B, Musquera, M, Prudhomme, T, Zeushner, P, Volpe, A, Baquero, RG, Kocak, B, Mirza, I, Stockle, M, Rohrsted, M, Canda, E, Roder, A, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Masieri, L, Serni, S, Breda, A, Campi, R. Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties
Martin, IJP, Guzmán, EF, Polo, MM, Martin, MA, Pascual, EF, Samaniego, MP, Pascual, EM, González, AR, González, BM, Sanz, IP, Jimenez, CP, Bonilla, AS, Morcillo, JCR, Fes, E, Suárez, JMG, Ortega, JL, Roca, JPD, Juanatey, FC. Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series
Territo, A, Afferi, L, Musquera, M, Sopena, HMG, Pecoraro, A, Campi, R, Gallioli, A, Etcheverry, B, Prudhomme, T, Vangeneugden, J, Ortved, M, Roder, A, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Mirza,, Fornara, P, Doumerc, N, Decaestecker, K, Serni, S, Vigues, F, Alcaraz, A, Breda, A. Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU)
De Oliveira, TMR, Somani, B, Browers, T, Veneziano, D, Redorta, JP, Biyani, CS, Kallidonis, P, Kasivisvanathan,, Zondervan, P, Petrut, B, Verze, P, Phe, VR, Raison, N, Silay, MS, Larche, A, Boissier, R, Liatsikos, E. SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU). EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress
Guerrero-Ramos, F, Chang, S, Dickstein, RJ, Jayram, G, Johnson, S, Joshi, S, Liu, JJ, Lotan, Y, Marcq, G, Satkunasivam, R, Schuckman, A, Steinberg, G, Taylor, J, Linback, T, Pruthi, R, Cheung, A, Tosone, C, Kamat, AM, Palou, J. A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study
Briones, JR, Guerrero-Ramos, F, Mercade, A, Abadia, IB, Rodriguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Arrabal, M, Cardo, AL, Rodriguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Espilez, R, Valcárcel, IG, Zalabardo, DS, Esquinas, C, Mengual, L, Borque-Fernando, N, Esteban, LM, Palou, J, Witjes, JA, Pineiro, LM. External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Regulations on pregnancy and parenthood during urology residency in European countries
Afferi, L, Margue, G, Toribio-Vázquez, C, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Gugerli, A, Siech, C, Vásquez, JL, Melsert, BM, Mertens, LS, Liatsikos, E, Somani, BK, Galliol, A, Pradere, B, Breda, A, Whitburn, J, Rangel, E. Regulations on pregnancy and parenthood during urology residency in European countries. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Annual updates of the European Association of Urology (EAU) / European Society for Paediatric Urology (ESPU) Pediatric Urology Guidelines: Are large-language models better than the usual structured methodology?
Van Uitert, A, 't Hoen, LA, Bussmann, M, Bezuidenhout, C, Ribal, M, Canfield, SE, Yuan, Y, Omar, M, Castagnetti, M, Burgu, B, Kelly, F, Quaedackers, J, Rawashdeh, Y, Silay, S, Bujon, A, Bogaert, G, Pakkasjarvi, N, Skott, M, Kennedy, U, Gnech, M, Radmayr, C. Annual updates of the European Association of Urology (EAU) / European Society for Paediatric Urology (ESPU) Pediatric Urology Guidelines: Are large-language models better than the usual structured methodology?. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma
Afferi, L, Grossmann, NC, Gallioli, A, Cannoletta, D, Moschini, M, Soria, F, Juvet, T, Potretzke, A, Djaladat, H, Kikuchi, E, Mari, A, Khene, Z, Raman, J, Sfakianos, JP, Boormans, JL, Antonelli, A, Abdollah, F, Ploussard, G, Boorjian, SA, Shariat, SF, Heidenreich, A, Mattei, A, Breda, A, Pradere, B. Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer
Elst, L, Miletic, M, Roussel, E, Verdijk, R, Alnajjar, H, Di Nardo, N, Perri, D, Kaur, A, Sirard, RB, Basile, G, Bandini, M, Lobo, J, Hatzichristodoulou, G, Salonia, A, Breda, A, Spiess, PE, Parnham, A, Falcone, M, Bozzini, G, Muneer, A, Watkin, N, Ayres, B, Brouwer, OR, Albersen, M. The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group
Kwok, JL, Somani, B, Sarica, K, Yuen, SKK, Zawadzki, M, Castellani, D, Persaud, S, Chai, C, Kamal, W, Tefik, T, Tursunkulo, AN, Soebhali, B, El Hajj, B, Ko, R, Fong, KY, Dragos, L, Tanidir, Y, Angerri, O, Traxer, O, Gauhar,. Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)
Fernández, CM, Sebio, A, Rincón, JO, Broto, JM, Benlloch, AM, Plaza, DM, Pousa, AL, Alegría, IG, Giuppi, M, Ballesteros, EC, Bernabeu, D, de Alava, E, Morales, CV. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS). Clinical & Translational Oncology. 2025; 27(3)DOI:10.1007/s12094-024-03602-5. PMID:39158802. IF:2.500(Q3/6D).
01/03/2025
Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship
Fa-Binefa, M, Serra, J, Moya, E, Crusi, X, Gich-Saladich, I, Valera, M. Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship. Hip International. 2025; 35(2)DOI:10.1177/11207000241306004. PMID:39757970. IF:1.100(Q3/7D).
01/03/2025
Effectiveness of a nurse training intervention in the emergency department to improve the diagnosis and treatment of stemi patients: EDUCAMI study
Congost, GB, Brugaletta, S, Cerezo, PG, Bernal, JV, Comalat, MB, Mejías, SM, Millán, LM, Evangelista, SR, Gabalda, JR, Ortega, JT, Garcia-Picart, J, Jimenez-Kockar, M, Aizpurua, DA, Campmany, MP, Momblan, MAM. Effectiveness of a nurse training intervention in the emergency department to improve the diagnosis and treatment of stemi patients: EDUCAMI study. HEART & LUNG. 2025; 70DOI:10.1016/j.hrtlng.2025.01.006. PMID:39813828. IF:2.600(Q1/2D).
01/03/2025
Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study
Moliner-Abós, C, Calvo-Barceló, M, Solé-Gonzalez, E, Martín, AB, Fluvià-Brugués, P, Sánchez-Vega, J, Vime-Jubany, J, Vallverdu, MF, Ferrer, MT, Tobias-Castillo, PE, Mancera, JCD, Vilardell-Rigau, P, Vila-Olives, R, Diez-López, C, Bayés-Genís, A, Aizpurua, DA, Ferreira-Gonzalez, I, Pérez, SM. Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study. EUROPEAN JOURNAL OF HEART FAILURE. 2025; 27(3)DOI:10.1002/ejhf.3463. PMID:39359034. IF:10.800(Q1/1D).
01/03/2025
ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS
Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
Surpassing protein specificity in biomimetics of bacterial amyloids
Sanchez, JM, Voltà-Durán, E, Parladé, E, Mangues, R, Villaverde, A, Vázquez, E, Unzueta, U. Surpassing protein specificity in biomimetics of bacterial amyloids. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2025; 296DOI:10.1016/j.ijbiomac.2025.139635. PMID:39788253. IF:8.500(Q1/1D).
01/03/2025
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
Gil-Berrozpe, GJ, Segura, AG, Sánchez-Torres, AM, Amoretti, S, Giné-Servén, E, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldán, A, Forte, MF, Castro, J, Bergé, D, Rodríguez, N, Ballesteros, A, Mas, S, Cuesta, MJ, Bernardo, M. Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92DOI:10.1016/j.euroneuro.2024.12.002. PMID:39721378. IF:6.700(Q1/1D).
01/03/2025
Safety and Efficacy of Tranexamic Acid in General Surgery
Park, LJ, Marcucci, M, Ofori, SN, Borges, FK, Nenshi, R, Kanstrup, CTB, Rosen, M, Landoni, G, Lomivorotov, V, Painter, TW, Xavier, D, Martinez-Zapata, MJ, Szczeklik, W, Meyhoff, CS, Chan, MTV, Simunovic, M, Bogach, J, Serrano, PE, Balasubramanian, K, Cadeddu, M, Yang, I, Kim, WH, Devereaux, PJ. Safety and Efficacy of Tranexamic Acid in General Surgery. JAMA Surgery. 2025; 160(3)DOI:10.1001/jamasurg.2024.6048. PMID:39813061. IF:14.900(Q1/1D).
01/03/2025
Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document
García-Cosío, MD, Cruzado, JM, Farrero, M, Peiró, MTB, Crespo, M, Jiménez, JFD, Molina, BD, Rivera, CF, Bravo, IPG, Jiménez, VL, Melilli, E, Pérez, SM, Tamajón, MLP, Sousa, DR, Calabia, ER, Marrero, DH. Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(3)DOI:10.1016/j.rec.2024.09.008. PMID:39442797. IF:4.900(Q1/2D).
01/03/2025
Identification of endoplasmic reticulum stress- associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm
Almendra-Pegueros, R, Rodriguez, C, Camacho, M, Sánchez-Infantes, D, Sánchez-Quesada, JL, Cáncer, S, Pérez-Marlasca, E, Medina-Gómez, G, Martinez-González, J, García-Redondo, AB, Galán, M. Identification of endoplasmic reticulum stress- associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm. CLINICAL SCIENCE. 2025; 139(6)DOI:10.1042/CS20242476. PMID:40072504. IF:7.700(Q1/2D).
01/03/2025
Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app
Cuixart, G, Corcoy, R, González, C. Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones-International Journal of Endocrinology and Metabolism. 2025; 24(1)DOI:10.1007/s42000-024-00609-z. PMID:39412732. IF:2.500(Q3/7D).
01/03/2025
Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide
Beltrans, JS, Guinart-Cuadra, A, Piedras, A, Recios, SM, Mulet, M, Atenza, CZ, Alejandre, J, Joaquíns, AB, Sullivans, IG, Lópezs, JS, Vidal, S, Majems, M. Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence
Mañosa, M, Oller, B, Garcia-Planella, E, Guardiola, J, Cañete, F, González-Muñoza, C, Camps, B, Calafat, M, Doménech, E. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. DIGESTIVE AND LIVER DISEASE. 2025; 57(3)DOI:10.1016/j.dld.2024.11.028. PMID:39730282. IF:3.800(Q2/3D).
01/03/2025
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial
Dajti, E, Villanueva, C, Berzigotti, A, Brujats, A, Albillos, A, Genescà, J, García-Pagán, JC, Colecchia, A, Bosch, J. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. JOURNAL OF HEPATOLOGY. 2025; 82(3)DOI:10.1016/j.jhep.2024.09.014. PMID:39303875. IF:33.000(Q1/1D).
01/03/2025
Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?
Añez, G, Torrente-Segarra, V, Bonet, M, Vilella, MC, Orpinell, L, Fernández, AP, Busquets-Pérez, N, Pascual-Pastor, M, Corominas, H, Diaz-Torne, C, Moya, P, De Agustin, JJ. Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?. Journal Of Ultrasound. 2025; 28(1)DOI:10.1007/s40477-024-00963-z. PMID:39424691. IF:(Q/D).
01/03/2025
Baseline PD-L1 expression in circulating neutrophils predicts immune-related adverse events (irAEs) in patients with extensive-stage small-cell lung cancer from CANTABRICO trial
Piedra, A, Guinart-Cuadra, A, Recio, SM, Mulet, M, Atenza, CZ, Alejandre, J, Beltran, JS, Joaquín, AB, Sullivan, IG, López, JS, Casado, MDI, Aperribay, EA, Paz-Ares, L, Tain, PD, Vega, ALM, Callejo, A, Martos, JLL, Dominguez, M, Vidal, S, Majem, M. Baseline PD-L1 expression in circulating neutrophils predicts immune-related adverse events (irAEs) in patients with extensive-stage small-cell lung cancer from CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
TACTI-004: A double-blinded, randomized phase III trial in patients with advanced/metastatic non-small cell lung cancer receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (P) and chemotherapy (C) versus placebo plus P plus C
Majem, M, O'Byrne, KJ, Lo Russo, G, Mueller, C, Triebel, F. TACTI-004: A double-blinded, randomized phase III trial in patients with advanced/metastatic non-small cell lung cancer receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (P) and chemotherapy (C) versus placebo plus P plus C. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis
Gillessen, S, Tombal, B, Turco, F, Choudhury, A, Rodriguez-Vida, A, Gallardo, E, Velho, PI, Nolè, F, Cruz, F, Loriot, Y, McDermott, R, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Polo, MH, da Trindade, KM, Preto, DD, Skoneczna, I, Lecouvet, F, Coens, C, Fournier, B, Saad, F. Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis. EUROPEAN UROLOGY. 2025; 87(3)DOI:10.1016/j.eururo.2024.11.027. PMID:39827019. IF:25.200(Q1/1D).
01/03/2025
Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer
Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, MCM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
First-line (1L) fulzerasib plus cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study
Majem, M, Gregorc, V, Lo Russo, G, Maio, M, Salvagni, S, Calderon, VG, Cao, MG, Contreras, SS, Koumarianou, A, Bearz, A, Caro, RB, Viteri, S, Sanmamed, MF, Zagouri, F, Bueno, MTM, Zhang, Y, Shan, Y, Zhu, H, Rosell, R. First-line (1L) fulzerasib plus cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial
Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, CM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025
Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital
Rueda-Lara, A, Viñal, D, Martínez-Pérez, D, Alameda-Guijarro, M, Martin-Montalvo, G, Martínez-Recio, S, Peña-Lopez, J, Jiménez-Bou, D, Ruíz-Gutiérrez, I, García-Leal, A, Zwisler-Contreras, P, Ghanem, I, Custodio, AB, Pérez-Wert, P, Gutiérrez-Sainz, L, Palacios, ME, Feliu, J, Rodríguez-Salas, N. Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital. ONCOLOGIST. 2025; 30(3)DOI:10.1093/oncolo/oyaf027. PMID:40152315. IF:4.200(Q2/3D).
01/03/2025
CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model
Szafranska, J, Batto, V, Alcaraz, J, Guinart-Cuadra, A, Brujats, A, Fajardo, J, Acin, V, Garcia, H, Casani, L, Villanueva, C, Ferré, M, del Olmo, TV, Tapias, EA. CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103704. PMID:. IF:4.200(Q1/1D).
01/03/2025
Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens
Kelley, J, Hissong, E, Szafranska, J, Qin, LH, Lamps, L, Jessurun, J. Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102849. PMID:. IF:4.200(Q1/1D).
01/03/2025
Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas
D'Angelo, E, Kingsley, L, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103197. PMID:. IF:4.200(Q1/1D).
01/03/2025
Methylation Profiling of Small Cell Carcinoma Hypercalcemic Type (SCCOHT) Identifies Three Groups with Distinct Clinical and Morphological Characteristics
Khubrani, R, Elyas, N, Hamidi, D, Stephan, L, Fotovati, R, Kommoss, F, Kommoss, F, Domecq, C, Hamel, N, Wang, YM, Huntsman, D, Zamarin, D, Boroujeni, AM, Chapel, D, Soslow, R, Mccluggage, G, Espinosa, I, Foulkes, W, Tessier-Cloutier, B. Methylation Profiling of Small Cell Carcinoma Hypercalcemic Type (SCCOHT) Identifies Three Groups with Distinct Clinical and Morphological Characteristics. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103244. PMID:. IF:4.200(Q1/1D).
01/03/2025
Histologic and Clinical Features of Esophageal Squamous Dysplasia: A Comparative Analysis of Basaloid, Classic, Differentiated, Spindle Cell, and Verrucous Variants
Hein, A, Szafranska, J, Jessurun, J, Panarell, N. Histologic and Clinical Features of Esophageal Squamous Dysplasia: A Comparative Analysis of Basaloid, Classic, Differentiated, Spindle Cell, and Verrucous Variants. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102833. PMID:. IF:4.200(Q1/1D).
01/03/2025
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC
Escamilla-Gómez, V, Gutiérrez, VG, Alcalde-Mellado, P, Astibia-Mahillo, B, Chinea-Rodriguez, A, López-Corral, L, Acera-Gómez, M, Ochando, MKT, Borrego, AB, Pinedo, LG, Ripa, TZ, Vicent, MG, Benzaquén, A, García, II, Cantó, PA, Montoro, J, Martín-Domínguez, FM, Orti, G, Valcárcel, D, Benitez-Carabante, MI, Diaz-de-Heredia, C, Cañamero, E, Ferrá, C, García-Cadenas, I, Redondo, S, Sisinni, L, Perez-Martínez, A, Mussetti, A, Garcia-Mañó, L, Palomo-Moraleda, MD, González-Sierra, PA, Jurado, M, Perez-Simon, JA. Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC. BONE MARROW TRANSPLANTATION. 2025; 60(3)DOI:10.1038/s41409-024-02483-0. PMID:39663471. IF:5.200(Q1/1D).
01/03/2025
Breast radiotherapy planning: A decision-making framework using deep learning
Gallego, P, Ambroa, E, Pérezalija, J, Jornet, N, Anson, C, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A., Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. Breast radiotherapy planning: A decision-making framework using deep learning. MEDICAL PHYSICS. 2025; 52(3)DOI:10.1002/mp.17527. PMID:39625151. IF:3.200(Q1/3D).
01/03/2025
Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.
Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.. Neurologia. 2025; 40(2)DOI:10.1016/j.nrleng.2023.04.008. PMID:37419211. IF:(Q/D).
01/03/2025
Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results
Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).
01/03/2025
Depressive Symptoms and Amyloid Pathology
Wiels, WA, Oomens, JE, Engelborghs, S, Baeken, C, von Arnim, CAF, Boada, M, Didic, M, Dubois, B, Fladby, T, van der Flier, WM, Frisoni, GB, Froehlich, L, Gill, KD, Grimmer, T, Hildebrandt, H, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Lee, DY, Lleo, A, Martinez-Lage, P, de Mendonca, A, Meyer, PT, Kapaki, EN, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sanchez-Juan, P, Santana, I, Sarazin, M, Scarmeas, N, Skoog, I, Snyder, PJ, Sperling, RA, Villeneuve, S, Wallin, A, Wiltfang, J, Zetterberg, H, Ossenkoppele, R, Verhey, FRJ, Vos, SJB, Visser, PJ, Jansen, WJ. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025; 82(3)DOI:10.1001/jamapsychiatry.2024.4305. PMID:39841452. IF:17.100(Q1/1D).
01/03/2025
Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica
Fraga Rodríguez GM, Devolder Nicolau, A. Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica. Anales de Nefrología Pediátrica. 2025; 1(10)DOI:. PMID:. IF:(Q/D).
01/03/2025
Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.
Majoie M, Visser A, Ulubas M, van Mastrigt G, Alonso-Coello P, Valli C, Niño de Guzman E, Gartlehner G, Nussbaumer-Streit B, Klerings I, James R, Service D, Evers S, Kleijnen J, Leone M, Verstegen D. Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.. Neurology. Education. 2025; 4(1)DOI:10.1212/NE9.0000000000200198. PMID:40041757. IF:(Q/D).
01/03/2025
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus
Villaverde, S, Pedrero-Tomé, R, Papaevangelou, V, Syridou, G, Karagiannidou, S, Lyall, H, Payne, H, Frick, MA, Soler-Palacín, P, Baquero-Artigao, F, Rodríguez-Molino, P, Fortuny-Guasch, C, Rios-Barnés, M, Sánchez-Mateos, M, Saavedra-Lozano, J, Bringué, X, Moliner, E, Castells, L, Muga, O, Vives-Oños, I, Gkentzi, D, Lombardi, G, Tagarro, A, Colino, E, Couceiro, JA, Rojo, P, de Vergas, J, Blázquez-Gamero, D. Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2025; 44(3)DOI:10.1097/INF.0000000000004583. PMID:39383383. IF:2.200(Q2/3D).
01/03/2025
NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03
Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
Factors associated with discharge home in older patients admitted to emergency department observation units: Looking for a predictive scale
Montero-Pérez, FJ, Bajo-Fernández, I, Castillo, JGD, Burillo-Putze, G, Jacob, J, Aguiló, S, Pinera-Salmerón, P, Alquezar-Arbé, A, Fernández-Alonso, C, Llorens, P, Cho, JUH, Casado-Ramón, B, Gayoso-Martín, S, Sánchez-Sindín, G, Fernández-Alvarez, ME, Gallardo-Vizcaíno, P, Romero-Carrete, C, Llauger, L, Vázquez-Rey, V, Calle-Fernández, S, Cañete, M, Ruescas, E, Fernández-Salgado, F, Miró, O. Factors associated with discharge home in older patients admitted to emergency department observation units: Looking for a predictive scale. JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2025; 31(2)DOI:10.1111/jep.14124. PMID:39167727. IF:2.100(Q2/3D).
28/02/2025
Acute Influenza Virus-Associated Encephalitis and Other Neurological Complications in Severe Hospitalized Laboratory-Confirmed Influenza Cases-Catalonia 2010-2020
Ciruela, P, Soldevila, N, Torner, N, Basile, L, Mosquera, MD, Marcos, MA, Martínez, A, Jané, M, Rius, C, Domínguez, A. Acute Influenza Virus-Associated Encephalitis and Other Neurological Complications in Severe Hospitalized Laboratory-Confirmed Influenza Cases-Catalonia 2010-2020. Pathogens. 2025; 14(3)DOI:10.3390/pathogens14030237. PMID:40137722. IF:3.300(Q2/5D).
27/02/2025
NOTCH3 Variant Position Affects the Phenotype at the Pluripotent Stem Cell Level in CADASIL
Bugallo-Casal, A, Muiño, E, Bravo, SB, Hervella, P, Arias-Rivas, S, Rodríguez-Yáñez, M, Vara-León, E, Quintas-Rey, R, Perez-Gayol, L, Maisterra-Santos, O, Pizarro-Gonzálvez, J, Martorell-Riera, MR, Vives-Bauzá, C, Fernández-Cadenas, I, Castillo, J, Campos, F. NOTCH3 Variant Position Affects the Phenotype at the Pluripotent Stem Cell Level in CADASIL. NEUROMOLECULAR MEDICINE. 2025; 27(1)DOI:10.1007/s12017-025-08840-6. PMID:40016442. IF:3.900(Q2/3D).
27/02/2025
Relevance of persistent perfusion deficits on clinical outcomes after successful endovascular treatment: a prospective serial magnetic resonance study
Carbó , AV, Palomar, A, Laredo, C, Werner, M, Dorado, L, Remollo, S, Munuera, J, Puig, J, Silva, Y, de la Ossa, NP, Gomis, M, Bustamante, A, Castaño , C, Muñoz , L, Domenech, S, Terceño , M, Millan, M, Hernández-Pérez, M. Relevance of persistent perfusion deficits on clinical outcomes after successful endovascular treatment: a prospective serial magnetic resonance study. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1478240. PMID:40083459. IF:2.800(Q2/5D).
27/02/2025
Impact of the dispersive patch placement on dissipated power in radiofrequency ablation for pulmonary vein isolation via a virtual patient study
Anees, M, Weidmann, ZM, Medel, DV, Guerra, JM, Gerardo-Giorda, L, Petras, A. Impact of the dispersive patch placement on dissipated power in radiofrequency ablation for pulmonary vein isolation via a virtual patient study. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-90158-1. PMID:40011542. IF:3.900(Q1/2D).
26/02/2025
A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer
Mercè, F, Asla, Q, Illana, FJ, Victòria, F, Javier, HL, Marta, S, Iglesias, C, Webb, SM, Aulinas, A. A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer. Familial Cancer. 2025; 24(1)DOI:10.1007/s10689-025-00449-9. PMID:40009226. IF:2.000(Q3/7D).
26/02/2025
Citrate-Assisted Regulation of Protein Stability and Secretability from Synthetic Amyloids
López-Laguna, H, Favaro, MTP, Chellou-Bakkali, S, Voltà-Durán, E, Parladé, E, Sánchez, J, Corchero, JL, Unzueta, U, Villaverde, A, Vázquez, E. Citrate-Assisted Regulation of Protein Stability and Secretability from Synthetic Amyloids. ACS Applied Materials & Interfaces. 2025; 17(10)DOI:10.1021/acsami.4c20784. PMID:40009529. IF:8.200(Q1/2D).
24/02/2025
Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkers
González, AC, Goossens, J, Campuzano, EV, Sala, I, Sánchez-Saudinós, MB, Rodríguez-Baz, I, Lidón, L, Perlaza, D, Bejanin, A, Haapasalo, A, Fortea, J, Alcolea, D, Lleo, A, Vanmechelen, E, Belbin, O. Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkers. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01685-y. PMID:39994784. IF:7.600(Q1/1D).
21/02/2025
Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study
Paja, M, Soto, A, Hanzu, FA, Guerrero-Pérez, F, Cámara, R, Moure, D, Gálvez, A, Simó-Servat, A, Villar-Taibo, R, Calatayud, M, Vicente, A, Recio-Córdova, JM, Serra, G, Rojas-Marcos, PM, Parra-Ramírez, P, Araujo-Castro, M, Librizzi, S, Irigaray, A, Ollero, D, Aznar, S, Muñoz, F, Aulinas, A, González-Fernández, L, García-Centeno, R, Egaña, N, González-Vidal, T, Menéndez, E, Delgado, AM, Abarca, J, Sottile, J, Picó, AM, Novo, C, Ortiz, I, Tenorio, C, de León, R, de Pablos-Velasco, P, Crespo, C, Peñalver, D, Díaz-Soto, G, Puig-Domingo, M, Biagetti, B. Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1529418. PMID:40060376. IF:4.600(Q1/3D).
21/02/2025
How an urban regeneration programme impact people's health and wellbeing: an evaluation from citizen's perception using concept mapping
Urtaran-Laresgoiti, M, Novoa, AM, Martin, S, Pérez, K. How an urban regeneration programme impact people's health and wellbeing: an evaluation from citizen's perception using concept mapping. BMC PUBLIC HEALTH. 2025; 25(1)DOI:10.1186/s12889-025-21827-z. PMID:39984935. IF:3.600(Q1/2D).
21/02/2025
Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study
Amigó, N, Castelblanco, E, Julve, J, Martínez-Micaelo, N, Alonso, N, Hernández, M, Ribalta, J, Guardiola, M, Torán-Monserrat, P, Lopez-Lifante, V, Herrero-Alonso, C, Arteaga, I, Ortega, E, Franch-Nadal, J, Mauricio, D. Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02636-5. PMID:39985069. IF:10.600(Q1/1D).